JP2022552158A5 - - Google Patents
Info
- Publication number
- JP2022552158A5 JP2022552158A5 JP2022520600A JP2022520600A JP2022552158A5 JP 2022552158 A5 JP2022552158 A5 JP 2022552158A5 JP 2022520600 A JP2022520600 A JP 2022520600A JP 2022520600 A JP2022520600 A JP 2022520600A JP 2022552158 A5 JP2022552158 A5 JP 2022552158A5
- Authority
- JP
- Japan
- Prior art keywords
- indazole
- carboxamide
- methyl
- alkyl
- carbamoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909920P | 2019-10-03 | 2019-10-03 | |
| US62/909,920 | 2019-10-03 | ||
| PCT/US2020/053882 WO2021067654A1 (en) | 2019-10-03 | 2020-10-02 | Indazole carboxamides as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022552158A JP2022552158A (ja) | 2022-12-15 |
| JP2022552158A5 true JP2022552158A5 (cg-RX-API-DMAC7.html) | 2023-09-06 |
| JP7600228B2 JP7600228B2 (ja) | 2024-12-16 |
Family
ID=73014622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520600A Active JP7600228B2 (ja) | 2019-10-03 | 2020-10-02 | キナーゼ阻害剤としてのインダゾールカルボキサミド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12275721B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4037772B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7600228B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220079593A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115087651B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020357986A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3153083A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2969756T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291828A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022003769A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021067654A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102906523B1 (ko) | 2018-09-13 | 2025-12-30 | 브리스톨-마이어스 스큅 컴퍼니 | 수용체-상호작용 단백질 키나제 1 (ripk1) 억제제로서의 1h-인다졸 카르복스아미드 |
| KR102793119B1 (ko) | 2018-09-13 | 2025-04-07 | 브리스톨-마이어스 스큅 컴퍼니 | 키나제 억제제로서의 인다졸 카르복스아미드 |
| AR123793A1 (es) | 2020-10-19 | 2023-01-11 | Bristol Myers Squibb Co | Compuestos de triazolopiridinilo como inhibidores de quinasas |
| CN114989079B (zh) * | 2022-06-21 | 2023-06-23 | 中国药科大学 | Ripk1激酶靶点抑制剂及其医药用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| KR101061599B1 (ko) | 2008-12-05 | 2011-09-02 | 한국과학기술연구원 | 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물 |
| WO2010068287A2 (en) | 2008-12-11 | 2010-06-17 | Angion Biomedica Corp. | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| US9315491B2 (en) | 2009-12-28 | 2016-04-19 | Development Center For Biotechnology | Pyrimidine compounds as mTOR and PI3K inhibitors |
| BR112012023021A2 (pt) * | 2010-03-16 | 2016-05-31 | Dana Farber Cancer Inst Inc | compostos de indazol e seus usos |
| USRE47009E1 (en) | 2011-02-01 | 2018-08-28 | The Children's Hospital Of Philadelphia | HDAC inhibitors and therapeutic methods using the same |
| KR20130077390A (ko) | 2011-12-29 | 2013-07-09 | 제이더블유중외제약 주식회사 | 단백질 키나아제 저해활성을 가지는 6-아미노-3-카복스아미도인다졸 유도체 |
| US9783573B2 (en) | 2012-09-18 | 2017-10-10 | Bristol-Myers Squibb Company | IAP antagonists |
| LT3580220T (lt) | 2017-02-13 | 2021-12-27 | Bristol-Myers Squibb Company | Aminotriazolopiridinai, kaip kinazės inhibitoriai |
| JP2020526499A (ja) | 2017-07-05 | 2020-08-31 | シーエス ファーマテック リミテッド | Egfrチロシンキナーゼの臨床上重要な突然変異体の選択的阻害剤 |
| CN111566103B (zh) | 2017-10-30 | 2023-06-23 | 百时美施贵宝公司 | 作为激酶抑制剂的氨基咪唑并吡嗪 |
| US11618753B2 (en) | 2018-01-26 | 2023-04-04 | Bristol-Myers Squibb Company | Aminopyrrolotriazines as kinase inhibitors |
| KR102793119B1 (ko) | 2018-09-13 | 2025-04-07 | 브리스톨-마이어스 스큅 컴퍼니 | 키나제 억제제로서의 인다졸 카르복스아미드 |
| KR102906523B1 (ko) | 2018-09-13 | 2025-12-30 | 브리스톨-마이어스 스큅 컴퍼니 | 수용체-상호작용 단백질 키나제 1 (ripk1) 억제제로서의 1h-인다졸 카르복스아미드 |
| AR123793A1 (es) | 2020-10-19 | 2023-01-11 | Bristol Myers Squibb Co | Compuestos de triazolopiridinilo como inhibidores de quinasas |
-
2020
- 2020-10-02 US US17/762,771 patent/US12275721B2/en active Active
- 2020-10-02 IL IL291828A patent/IL291828A/en unknown
- 2020-10-02 JP JP2022520600A patent/JP7600228B2/ja active Active
- 2020-10-02 CA CA3153083A patent/CA3153083A1/en active Pending
- 2020-10-02 CN CN202080069790.2A patent/CN115087651B/zh active Active
- 2020-10-02 WO PCT/US2020/053882 patent/WO2021067654A1/en not_active Ceased
- 2020-10-02 ES ES20797277T patent/ES2969756T3/es active Active
- 2020-10-02 EP EP20797277.9A patent/EP4037772B1/en active Active
- 2020-10-02 AU AU2020357986A patent/AU2020357986A1/en not_active Abandoned
- 2020-10-02 KR KR1020227014776A patent/KR20220079593A/ko active Pending
- 2020-10-02 MX MX2022003769A patent/MX2022003769A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| RU2420525C2 (ru) | Производные оксимов и их получение | |
| RU2014142598A (ru) | Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в | |
| JP2007501189A5 (cg-RX-API-DMAC7.html) | ||
| JP2010533158A5 (cg-RX-API-DMAC7.html) | ||
| RU2009118602A (ru) | Производное индола | |
| RU2008117170A (ru) | Пиримидинамидные соединения как ингибиторы pgds | |
| JP2006077019A5 (cg-RX-API-DMAC7.html) | ||
| RU2014107463A (ru) | Селективные ингибиторы протеинкиназ | |
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| CA2522024A1 (en) | Cgrp receptor antagonists | |
| RU2007138978A (ru) | Гетероциклическое соединение | |
| RU2004112766A (ru) | Ингибиторы киназы-3 гликогенсинтазы (gsk-3) для лечения глаукомы | |
| RU2407740C2 (ru) | Гетеробициклические сульфонамидные производные для лечения диабета | |
| JP2006517572A5 (cg-RX-API-DMAC7.html) | ||
| HRP20141190T1 (hr) | Disupstituirani derivati piridina kao antikancerogena sredstva | |
| JP2019537594A5 (cg-RX-API-DMAC7.html) | ||
| JP2012510989A5 (cg-RX-API-DMAC7.html) | ||
| JP2008525502A5 (cg-RX-API-DMAC7.html) | ||
| JP2007519694A5 (cg-RX-API-DMAC7.html) | ||
| RU2010115574A (ru) | Замещенные амиды, фармацевтическая композиция на их основе, способ лечения заболевания, чувствительного к btk, способ повышения чувствительности раковых клеток к химиотерапии, способ уменьшения ошибок при приеме лекарства и улучшения соблюдения схемы лечения, способ ингибирования гидролиза атф, способ определения присутствия btk в образце и способ ингибирования активности в-клеток | |
| RU2010132644A (ru) | Производные индола и индазола, обладающие консервирующим действием по отношению к клеткам, тканям и органам | |
| JP2005504101A5 (cg-RX-API-DMAC7.html) | ||
| RU2011103789A (ru) | Производное триазола или его соль | |
| JP2010540462A5 (cg-RX-API-DMAC7.html) |